These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3444799)

  • 81. Manifestations and outcome of treatment of thyrotoxicosis: a clinical study.
    Tan CE; Wang KW; Chew LS; Rajasoorya C; Lim HS
    Ann Acad Med Singap; 1990 Nov; 19(6):798-801. PubMed ID: 2130740
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Serum thyroid-stimulating hormone determination by sensitive immunoradiometric assay (IRMA)].
    Sakai R; Kanai M; Maruyama K; Sato S; Kobayashi M
    Radioisotopes; 1986 Nov; 35(11):605-8. PubMed ID: 3809611
    [No Abstract]   [Full Text] [Related]  

  • 83. Serotonin syndrome unmasking thyrotoxicosis.
    Ronan GP; Ronan N; McGettigan S; Browne G
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30850570
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fetal and neonatal thyrotoxicosis.
    Batra CM
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S50-4. PubMed ID: 24251220
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Incidence and mechanism of spurious increase in serum thyrotropin.
    Howanitz PJ; Howanitz JH; Lamberson HV; Ennis KM
    Clin Chem; 1982 Mar; 28(3):427-31. PubMed ID: 7067081
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Thyrotoxicosis increases right to left shunt in congenital cyanotic heart disease.
    Orme SM; Sebastian JP; Page MD; Cowan C; Belchetz PE
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):253-6. PubMed ID: 8370139
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tumor progression with thyrotoxicosis on differentiated thyroid carcinoma due to thyrotropin receptor stimulation: is tyrosine kinase inhibitors the cause of thyroid stimulating hormone receptor antibody positivity?
    Notsu M; Kanasaki K
    Ann Palliat Med; 2022 Sep; 11(9):2806-2809. PubMed ID: 36217632
    [No Abstract]   [Full Text] [Related]  

  • 88. Paranoid reaction and underlying thyrotoxicosis.
    Kamlana SH; Holms L
    Br J Psychiatry; 1986 Sep; 149():376-7. PubMed ID: 3779306
    [No Abstract]   [Full Text] [Related]  

  • 89. Urticaria associated with thyrotoxicosis.
    Henderson CA; Highet AS
    Clin Exp Dermatol; 1995 Mar; 20(2):173-4. PubMed ID: 8565260
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Thyrotoxicosis insistiates: report of 17 cases.
    Snyder S; Jaffe M
    Ann Intern Med; 1997 Jul; 127(1):88. PubMed ID: 9214262
    [No Abstract]   [Full Text] [Related]  

  • 91. Thyroid-associated eye disease.
    Freeman AG
    Lancet; 1991 Aug; 338(8764):454-5. PubMed ID: 1678120
    [No Abstract]   [Full Text] [Related]  

  • 92. Non-myeloproliferative Pancytopenia: A Rare Presentation of Thyrotoxicosis.
    Rahmathullah I; Umakanth M; Singhapathirane S
    Cureus; 2023 Feb; 15(2):e35076. PubMed ID: 36945271
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carbimazole in respiratory failure.
    Jenkins PF; Knapp MS
    Br Med J; 1979 Mar; 1(6165):719-20. PubMed ID: 435750
    [No Abstract]   [Full Text] [Related]  

  • 94. Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis.
    Michie W; Duncan T; Hamer-Hodges DW; Bewsher PD; Stowers JM; Pegg CA; Hems G; Hedley AJ
    Lancet; 1971 Mar; 1(7698):508-14. PubMed ID: 4100433
    [No Abstract]   [Full Text] [Related]  

  • 95. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Role of TSH measurements in predicting the outcome of treatment for Graves' disease following drug therapy.
    Wood WE
    Postgrad Med J; 1995 Apr; 71(834):222-3. PubMed ID: 7784282
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?
    Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA
    Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Thyrotropin receptor antibodies associated with post-operative relapse of thyrotoxicosis in a pregnancy complicated by neonatal thyrotoxicosis.
    Wilson R; Fraser WD; Gray CE; Alroomi LG; Thomson JA
    Scott Med J; 1990 Feb; 35(1):21-2. PubMed ID: 2315685
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease.
    Wilson R; McKillop JH; Henderson N; Pearson DW; Thomson JA
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):151-6. PubMed ID: 3491692
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.